---
$id: https://graph.org.ai/products/commodity/51373404
$type: Product
source: UNSPSC
code: "51373404"
title: "Acetaminophen/codeine/guaifenesin/phenylpropanolamine"
class: "51373400"
classTitle: "Combination opioid-containing antitussives and expectorants"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Acetaminophen/codeine/guaifenesin/phenylpropanolamine

**UNSPSC Code**: 51373404
**Class**: [Combination opioid-containing antitussives and expectorants](Combination opioid-containing antitussives and expectorants.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS. The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification. The second component of this combination drug is an opiate with the molecular formula C18H21NO3.H2O, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier Q830PW7520, chemically known as codeine, sulfate but more generally known as codeine, which bears U.S. National Institutes of Health Compound Identifier 223652. The European Medicines Agency schedules Codeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13424MIG. The World Health Organization schedules codeine in its Anatomical Therapeutic Chemical (ATC) Classification. The third component of this combination drug is an expectorant with the molecular formula C10H14O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 495W7451VQ, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears U.S. National Institutes of Health Compound Identifier 3516. The European Medicines Agency schedules Guaifenesin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07973MIG. The term GUAIFENESIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25 , No. 10 1971, List 11). The World Health Organization schedules guaifenesin in its Anatomical Therapeutic Chemical (ATC) Classification. The fourth component of this combination drug is an adrenergic agonist with the molecular formula C9H13NO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 33RU150WUN, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears U.S. National Institutes of Health Compound Identifier 4786. The European Medicines Agency schedules Phenylpropanolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09790MIG. The term PHENYLPROPANOLAMINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). The World Health Organization schedules phenylpropanolamine in its Anatomical Therapeutic Chemical (ATC) Classification.

